2-[3-[(3-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;2-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;bis(9-(4-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide);9-(5-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide;hexakis(platinum(2+));9-pyrazin-2-yl-2-(3-pyrazin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide

C168H109N25O6Pt6 — CID 158478565

IUPAC2-[3-[(3-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;2-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;bis(9-(4-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide);9-(5-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide;hexakis(platinum(2+));9-pyrazin-2-yl-2-(3-pyrazin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide
SMILESCc1ccnc(-n2c3[c-]c(-c4[c-]c(Oc5ccccn5)ccc4)ccc3c3ccccc32)n1.Cc1ccnc(-n2c3[c-]c(-c4[c-]c(Oc5ccccn5)ccc4)ccc3c3ccccc32)n1.Cc1cnc(-n2c3[c-]c(-c4[c-]c(Oc5cc(C)ccn5)ccc4)ccc3c3ccccc32)nc1.Cc1cnc(-n2c3[c-]c(-c4[c-]c(Oc5ccccn5)ccc4)ccc3c3ccccc32)nc1.Cc1cnc(-n2c3[c-]c(-c4[c-]c(Oc5ncccc5C)ccc4)ccc3c3ccccc32)nc1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].[c-]1c(Oc2cnccn2)cccc1-c1[c-]c2c(cc1)c1ccccc1n2-c1cnccn1
InChIInChI=1S/2C29H20N4O.3C28H18N4O.C26H15N5O.6Pt/c1-19-17-31-29(32-18-19)33-26-11-4-3-10-24(26)25-13-12-22(16-27(25)33)21-8-5-9-23(15-21)34-28-20(2)7-6-14-30-28;1-19-12-13-30-28(14-19)34-23-7-5-6-21(15-23)22-10-11-25-24-8-3-4-9-26(24)33(27(25)16-22)29-31-17-20(2)18-32-29;2*1-19-14-16-30-28(31-19)32-25-10-3-2-9-23(25)24-13-12-21(18-26(24)32)20-7-6-8-22(17-20)33-27-11-4-5-15-29-27;1-19-17-30-28(31-18-19)32-25-10-3-2-9-23(25)24-13-12-21(16-26(24)32)20-7-6-8-22(15-20)33-27-11-4-5-14-29-27;1-2-7-23-21(6-1)22-9-8-19(15-24(22)31(23)25-16-27-10-12-29-25)18-4-3-5-20(14-18)32-26-17-28-11-13-30-26;;;;;;/h2*3-14,17-18H,1-2H3;2*2-16H,1H3;2-14,17-18H,1H3;1-13,16-17H;;;;;;/q6*-2;6*+2
InChIKeyIRLOFYCMJZQJGQ-UHFFFAOYSA-N
MW3744.36 g/mol
LogP37.71
Rot. Bonds24

About 2-[3-[(3-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;2-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;bis(9-(4-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide);9-(5-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide;hexakis(platinum(2+));9-pyrazin-2-yl-2-(3-pyrazin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide

2-[3-[(3-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;2-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;bis(9-(4-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide);9-(5-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide;hexakis(platinum(2+));9-pyrazin-2-yl-2-(3-pyrazin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide (PubChem CID 158478565) has the molecular formula C168H109N25O6Pt6 and a molecular weight of 3744.36 g/mol. Its IUPAC name is 2-[3-[(3-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;2-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;bis(9-(4-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide);9-(5-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide;hexakis(platinum(2+));9-pyrazin-2-yl-2-(3-pyrazin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide.

Molecular Properties

Compound Name2-[3-[(3-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;2-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;bis(9-(4-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide);9-(5-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide;hexakis(platinum(2+));9-pyrazin-2-yl-2-(3-pyrazin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide
PubChem CID158478565
Molecular FormulaC168H109N25O6Pt6
Molecular Weight3744.36 g/mol
Exact Mass3741.69
IUPAC Name2-[3-[(3-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;2-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;bis(9-(4-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide);9-(5-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide;hexakis(platinum(2+));9-pyrazin-2-yl-2-(3-pyrazin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide
SMILESCc1ccnc(-n2c3[c-]c(-c4[c-]c(Oc5ccccn5)ccc4)ccc3c3ccccc32)n1.Cc1ccnc(-n2c3[c-]c(-c4[c-]c(Oc5ccccn5)ccc4)ccc3c3ccccc32)n1.Cc1cnc(-n2c3[c-]c(-c4[c-]c(Oc5cc(C)ccn5)ccc4)ccc3c3ccccc32)nc1.Cc1cnc(-n2c3[c-]c(-c4[c-]c(Oc5ccccn5)ccc4)ccc3c3ccccc32)nc1.Cc1cnc(-n2c3[c-]c(-c4[c-]c(Oc5ncccc5C)ccc4)ccc3c3ccccc32)nc1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].[c-]1c(Oc2cnccn2)cccc1-c1[c-]c2c(cc1)c1ccccc1n2-c1cnccn1
InChIInChI=1S/2C29H20N4O.3C28H18N4O.C26H15N5O.6Pt/c1-19-17-31-29(32-18-19)33-26-11-4-3-10-24(26)25-13-12-22(16-27(25)33)21-8-5-9-23(15-21)34-28-20(2)7-6-14-30-28;1-19-12-13-30-28(14-19)34-23-7-5-6-21(15-23)22-10-11-25-24-8-3-4-9-26(24)33(27(25)16-22)29-31-17-20(2)18-32-29;2*1-19-14-16-30-28(31-19)32-25-10-3-2-9-23(25)24-13-12-21(18-26(24)32)20-7-6-8-22(17-20)33-27-11-4-5-15-29-27;1-19-17-30-28(31-18-19)32-25-10-3-2-9-23(25)24-13-12-21(16-26(24)32)20-7-6-8-22(15-20)33-27-11-4-5-14-29-27;1-2-7-23-21(6-1)22-9-8-19(15-24(22)31(23)25-16-27-10-12-29-25)18-4-3-5-20(14-18)32-26-17-28-11-13-30-26;;;;;;/h2*3-14,17-18H,1-2H3;2*2-16H,1H3;2-14,17-18H,1H3;1-13,16-17H;;;;;;/q6*-2;6*+2
InChIKeyIRLOFYCMJZQJGQ-UHFFFAOYSA-N
XLogP37.71
TPSA329.87 Ų
H-Bond Donors
H-Bond Acceptors31
Rotatable Bonds24
Heavy Atoms205
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003744.36
LogP ≤ 537.71
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1031

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 2-[3-[(3-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;2-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;bis(9-(4-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide);9-(5-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide;hexakis(platinum(2+));9-pyrazin-2-yl-2-(3-pyrazin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[3-[(3-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;2-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;bis(9-(4-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide);9-(5-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide;hexakis(platinum(2+));9-pyrazin-2-yl-2-(3-pyrazin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide?
The IUPAC name of 2-[3-[(3-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;2-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;bis(9-(4-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide);9-(5-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide;hexakis(platinum(2+));9-pyrazin-2-yl-2-(3-pyrazin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide (CID 158478565) is 2-[3-[(3-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;2-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;bis(9-(4-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide);9-(5-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide;hexakis(platinum(2+));9-pyrazin-2-yl-2-(3-pyrazin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide.
What is the SMILES notation for 2-[3-[(3-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;2-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;bis(9-(4-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide);9-(5-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide;hexakis(platinum(2+));9-pyrazin-2-yl-2-(3-pyrazin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide?
The canonical SMILES for 2-[3-[(3-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;2-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;bis(9-(4-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide);9-(5-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide;hexakis(platinum(2+));9-pyrazin-2-yl-2-(3-pyrazin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide is Cc1ccnc(-n2c3[c-]c(-c4[c-]c(Oc5ccccn5)ccc4)ccc3c3ccccc32)n1.Cc1ccnc(-n2c3[c-]c(-c4[c-]c(Oc5ccccn5)ccc4)ccc3c3ccccc32)n1.Cc1cnc(-n2c3[c-]c(-c4[c-]c(Oc5cc(C)ccn5)ccc4)ccc3c3ccccc32)nc1.Cc1cnc(-n2c3[c-]c(-c4[c-]c(Oc5ccccn5)ccc4)ccc3c3ccccc32)nc1.Cc1cnc(-n2c3[c-]c(-c4[c-]c(Oc5ncccc5C)ccc4)ccc3c3ccccc32)nc1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].[c-]1c(Oc2cnccn2)cccc1-c1[c-]c2c(cc1)c1ccccc1n2-c1cnccn1.
What is the InChIKey of 2-[3-[(3-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;2-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;bis(9-(4-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide);9-(5-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide;hexakis(platinum(2+));9-pyrazin-2-yl-2-(3-pyrazin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide?
The InChIKey is IRLOFYCMJZQJGQ-UHFFFAOYSA-N. The full InChI is InChI=1S/2C29H20N4O.3C28H18N4O.C26H15N5O.6Pt/c1-19-17-31-29(32-18-19)33-26-11-4-3-10-24(26)25-13-12-22(16-27(25)33)21-8-5-9-23(15-21)34-28-20(2)7-6-14-30-28;1-19-12-13-30-28(14-19)34-23-7-5-6-21(15-23)22-10-11-25-24-8-3-4-9-26(24)33(27(25)16-22)29-31-17-20(2)18-32-29;2*1-19-14-16-30-28(31-19)32-25-10-3-2-9-23(25)24-13-12-21(18-26(24)32)20-7-6-8-22(17-20)33-27-11-4-5-15-29-27;1-19-17-30-28(31-18-19)32-25-10-3-2-9-23(25)24-13-12-21(16-26(24)32)20-7-6-8-22(15-20)33-27-11-4-5-14-29-27;1-2-7-23-21(6-1)22-9-8-19(15-24(22)31(23)25-16-27-10-12-29-25)18-4-3-5-20(14-18)32-26-17-28-11-13-30-26;;;;;;/h2*3-14,17-18H,1-2H3;2*2-16H,1H3;2-14,17-18H,1H3;1-13,16-17H;;;;;;/q6*-2;6*+2.
What are the key properties of 2-[3-[(3-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;2-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;bis(9-(4-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide);9-(5-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide;hexakis(platinum(2+));9-pyrazin-2-yl-2-(3-pyrazin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide?
2-[3-[(3-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;2-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;bis(9-(4-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide);9-(5-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide;hexakis(platinum(2+));9-pyrazin-2-yl-2-(3-pyrazin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide has a molecular weight of 3744.36 g/mol, XLogP of 37.71, 24 rotatable bonds, 0 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[(3-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;2-[3-[(4-methyl-2-pyridinyl)oxy]benzene-2-id-1-yl]-9-(5-methylpyrimidin-2-yl)-1H-carbazol-1-ide;bis(9-(4-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide);9-(5-methylpyrimidin-2-yl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide;hexakis(platinum(2+));9-pyrazin-2-yl-2-(3-pyrazin-2-yloxybenzene-2-id-1-yl)-1H-carbazol-1-ide is sourced from PubChem (CID 158478565), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).